Reddit Posts
Pharma AI - might still be too early
29 APRIL 2026, WHAT ARE THE BIGGEST WINNERS TODAY
Why is the ABSI Feb 20th chain so bloated? 26% SI vs. massive Call OI discrepancy.
LISTEN UP BALD DEGENERATES: Absci (ABSI) is the AI sleeper that's gonna fix your hairline and fill your bags. 🚀💊
MindWalk Holdings ($HYFT) looking kinda slept-on right now
The future of AI gains will be in De Novo Proteins. There is really only one way to invest early without going to Big Pharma
AMD’s AI announcement could light a fuse under some penny stocks tied to its ecosystem 🔥💾
$ABSI - $8 price target reiterated and big catalysts for their AI drug discovery platform
$ABSI has been quietly breaking out - is major announcement coming?
ABSI - earnings just in, is it time for AI in healthcare?
ABSI - Earnings just in, one of the best AI healthcare small caps?
FDA announces plans to phase out animal testing - bullish for AI biotech stocks?
FDA announces plans to phase out animal testing - bullish for AI biotech stocks?
$ABSI - FDA announces plans to phase out animal testing
$ABSI - FDA announces plans to phase out animal testing
$ABSI company said it could be eligible to receive up to $610 million in upfront fees and milestone payments from $MRK as part of a research collaboration agreement.
LIVE: GME, ABSI, HGSH, F & EAR Stocks. Where To Watch Stocks Live!
$ABSI , With the Early News. Flying Up..
$ABSI is up 63% at 7:26 am already on news
Mentions
$ABSI $RXRX new openai venture
$ABSI woah, my brother in law is rich
I'm glad I held onto those ABSI shares
Yeah, a decent chance biotech is the next phase of the AI play. I’ve got some nice positions in peptides/antibodies (ABCL/ABSI) and gene therapies (CRSP/BEAM/PRME). Also RXRX as a pure AI biotech play
Biotech: ABCL, ABSI, GENB, RXRX
I'm in this post and I hate it. Held 150,000 shares of $ABSI from $2.55 to $3, sold at $3 on March 28. Hit $6.20. FML. (It's gonna crash again after earnings; this is what it does, but _painnnnnnnn_.)
ABSI looking like it might be worth trillions.
ABSI. 30% short What are we waiting for?????
My scanner has been detecting ABSI multiple times today. Im not in it but seems to be having steady climb. Is it because announcing earnings ?
Good stuff, buddy. RXRX and ABSI look like candidates for cheap LEAPs with real payoff potential.
Yup, I've started going into gene therapy (e.g., CRSP, BEAM) and antibody/peptide design companies (e.g., ABSI, ABCL, GMAB) myself
#TLDR --- Ticker: ABSI Direction: Up Prognosis: Buy Shares (Targeting Double Digits) Catalyst: AI-generated quarterly injection for Alopecia (ABS-201) Bull Case: Insiders buying aggressively, proven platform, saves your hairline without breaking your junk. Current Hairline: Receding to the back of neck
AI medicine, because they are going to run out of hyped up stocks: RXRX ABCL SDGR ABSI
Started looking at this sub about a year ago and now I'm bag holding bullshit like: BB (Blackberry) RCAT ABSI LDI LUNR SMCI Blackberry...
Starting off take this post as you will, I’m no expert, I’m just a guy that likes to research companies and enjoys the thrill. I got into NUVB at 1.83 and now took some profits and put into these other two. First off is ABSI it feels a lot like NUVB and it’s going to be for long term play, due to if trials go well it could be the future of modern medicine. Second is VIVK, I see a lot of people throwing out info on it to try to get a pump, I am not not trying to get pump and dump, i mean of course I wouldn’t mind cashing if it does but I believe with everything VIVK has going on right now that it could potentially be the holy grail or then again could be nothing. I’ve read a lot of mixed reviews on VIVK, I’ve read a lot of good and bad facts about it. I just think they have finally got it figured out and are about to start pumping money right out of the ground. Could I eat my words in a day/week/month possibly but at the price it’s sitting at right now for everything they have to offer, it’s almost like losing if I don’t buy it lol I wouldn’t put anything in it you’re not prepared to lose but through a 100 in and see where it takes you. Don’t go throw your bag at these stocks as I stated above I’m not an expert, but I would recommend doing you’re own research on these two and if your gut tells you that you can see a profit then awesome.
Data infrastructure: VRT Satellites: GSAT and PL No brainer: JPM Covid buy: MPC Next up? Entered ABSI and RXRX today on the heavy heavy dips, entered NRIX back in April. Biotech / drug discovery has been walloped, but these 3 have things going for them. High risk obviously / not investment advice
ABSI was the play and it was so cheap! :/
Most AI is just companies Venmo’ing each other to fake profits, but the real game is AI that can create De Novo proteins. Veritasium literally did a whole video on how huge this tech is going to be for the world and since I can't read I have to fully trust this. And regular people no real entry point into that space even though every big player is investing billions. But I was able to find one. And they just happen to be the closest to curing balding. They even had to move up their dates and are holding a virtual seminar on Dec 11 to talk about their progress and probably drop some big news. So yeah I went all in on Feb 20 ABSI 8.00c.
Look at ABSI, it’s a stock that’s just beginning its run, got 9 strong buy analyst ratings too with a price target almost triple its current value
# **De Novo Proteins will be the future of AI** If you’ve seen the Veritasium video on AI protein design, you already know what’s coming. Link: https://www.youtube.com/watch?v=VGosZWBTFyY That video explains how AI can now predict and design proteins with extreme accuracy. Proteins are the machinery of life, and for the first time, we can build new ones intentionally. That's great and all, but where's the money? # **Why Absci (ABSI) Might Be the Smartest High-Risk, High-Reward Play in AI Right Now** AI has already changed how we think, write, and build. But the biggest transformation is about to happen in biology. The future of medicine won’t come from finding molecules in nature. It will come from designing new ones from scratch. That is what Absci does. They use generative AI to create de novo proteins—brand-new proteins built by design, not discovery. These can become new drugs, enzymes, or even regenerative treatments. It’s a total shift in how medicine is made. Absci’s system goes even further. Their AI designs millions of protein candidates, and their automated lab physically builds and tests them. The data then feeds back into the model so each new cycle gets smarter. They call it “AI Drug Creation,” and it’s exactly what it sounds like—AI making new drugs that have never existed before. # **Why Absci Is Different** Every other serious player in this field is locked inside a major corporation or still private. - DeepMind and Isomorphic Labs belong to Google. - EvolutionaryScale is funded by Amazon. - Recursion is partnered with Roche. Absci is the only independent, publicly traded company focused entirely on AI-based de novo protein design. That gives regular investors a unique shot at a field that will likely reshape biotech over the next decade. They also have partnerships with Almirall, Oracle, and AMD, which gives them both scientific and computing credibility. And they recently raised enough capital to be funded well into 2028. That means they can deliver data without constant fundraising or dilution. # **The Baldness Program That Could Change Everything** Absci’s most exciting project right now is ABS-201, a potential treatment for pattern baldness. It targets the prolactin receptor, which plays a role in hair follicle miniaturization. In testing, ABS-201 achieved full hair regrowth in 22 days in mice, while 5 percent minoxidil (Rogaine’s active ingredient) only achieved partial regrowth in the same period. In primate studies, it showed over 90 percent bioavailability and a long half-life, meaning it could be taken once every few months instead of daily. If those results hold up in humans, it would outperform both Rogaine and finasteride by a wide margin. Absci is hosting a baldness-focused conference on December 11 where they are expected to reveal new progress and additional data on this program. If they confirm results close to what they’ve shown so far, it could be a major turning point for the company and the stock. The hair loss market has more than 80 million potential patients in the U.S. alone, with billions spent annually on treatments that barely work. A truly effective biologic would be a category killer. # **Where Things Stand** Absci also has ABS-101, a drug in human testing for inflammatory bowel disease. Results from that study will be the company’s first human clinical data and could validate their AI platform in real-world medicine. Between that and the upcoming December 11 event, Absci has multiple near-term catalysts that could drive significant attention and value. Their partnerships, data generation speed, and multi-year cash runway give them breathing room to prove their model works. # **The Risk and the Reward** Absci is small, volatile, and early. It’s not a stock for anyone who needs safety or short-term certainty. But it is one of the few companies sitting on the edge of a once-in-a-generation scientific shift. If AI-designed proteins become standard in drug creation, Absci could be the name that helped start it. The upside is enormous, even if the path there is risky. # **TL;DR** Ticker: ABSI - Focus: AI-driven design of new proteins for medicine and therapy - Why unique: Only public company fully dedicated to this field - Upcoming catalyst: Baldness program (ABS-201) update on December 11 - Other program: ABS-101 for inflammatory bowel disease, human testing already underway - Cash runway: Funded into 2028 - Potential: Could be the NVIDIA of biotech if AI protein design takes off - Risk: Early-stage biotech volatility, dependent on data
ABSI needs to announve partnership with OpenAi
which should i full port: APLD COIN SOXL BULL ABSI TMC
Oops, I meant ABSI. it’s trading close to $4 today. I had it included earlier but removed it and forgot to update the title. Good luck!
. a ultra high wealth individual is fully funding our expanded access and and Glioblastoma trials .ABSI has been our secret partner for three years .meeting set with FDA w/ BRIEFING book for mtnbc .we have FAST TRACK DESIGNATION for mTNBC .PRECLINIC SHOWED 98% improvement in lung mets .NEW ARM LL + checkpoint inhibitor FOR PATIENT with PROGRESSING Disease in CRC .doubled overall survival. .mTNBC TRIAL P2 RESUMING PER 10K .mTNBC PTS STILL LIVING 5YRS-P value .0007 .up-regulates Pd-L1 making all patients eligible for checkpoint inhibitors tx .STROKE RECOVERY .reverses fibrosis from any cause p value 0.01 ,leads to funded PF .GATES FUNDING THE HELL OUT OF SACHA .ART+bNAB+LL=HIV cure .Alz trial Jan-filly funded .Long acting partner ABSCI .Berlin scientist just cured the 8th HIV pts requested LL .LH NIH grant .Latch HIV cure trial funded by AMFAR . LL CROSSES BBB &PLACENTA .FcRn mutation blocks CCr5 in fetus .Engaged SYNEOS .Transferred MNFR Tec . Samsung restructured debt til”profitable “
ABSI continuing to cook this month
giving all my regards to BITF and ABSI today
Are you still keep an eye on ABSI?
Been holding a sizeable position in ABSI for months! Happy to see the movement the last couple days. A rising tide lifts all boats
Yes they did...ABSI is nearly 13% up today. I have the feeling that If the momentum keeps going for AMD, the same will happen with many of those pennys that have contracts with AMD... Hoping to go to the moon...
Time to full port ABSI
JP Morgan put a buy rating on ABSI Friday. AMD & ORCL taking stakes. Mods not doing this subreddit any favors by hiding this ticker! Read the room!
I would’ve like to see what you wrote. I’ve been following ABSI for some time now. Super interesting company. +The big wirehouse analysts’ follow this ticker..
ABSI to the moon or to the lab trash bin, no in-between.
ABSI showing strength!! Up 4 days on above avg volume. 25% of the float is short..... so we might see a short squeeze when news is released!
Possible Monday / week plays on my radar as of right now: **$ABP** : Momentum, Hype. Next big Holding co pump? **$ASST** : Any PR will pump this at this levels 20%+. Anticipation. Dilutive. High short stats. Bitcoin. **$OPEN** : swings from bottom, retail juggernaut. **$RELI** : Crypto ___ Lounge finds : **$ABSI** : u/mamegan : Big float, high short stats. Oddly timed PR(Sep-21) 64M Financing : https://finviz.com/news/171651/absci-corporation-absi-secures-64m-financing-to-drive-ai-drug-discovery-through-2028 ___ Watchlist PM : **$QLGN** : massive closing Friday night. **$YAAS** : 🇨🇳 sold at the top looking for dip. Volatile, great swings. **$ADAP** : looking for bottom swings on this Reddit turd. **$ORIS** : 🇨🇳
ABSI: had this one on my watchlist, will try to get in early pre-market https://finance.yahoo.com/news/absci-corporation-absi-secures-64m-132643731.html
I’m in healthcare and am curious why RXRX has not blown up yet? They are an AI pharm startup partnered with NVDA and may have the first non-surgical treatment for FAP. ABSI is in a similar situation. No clue
What do you think of ABSI now? Still holding? Will they recover?
My big bet is on RXRX, and some ABSI
If only ONDS didn't file for dilution I would feel so much better. Anyone buying today or waiting for the results? Also considering ABSI.
ABSI earnings disappointed. Hop on while it's discounted!!
ABSI 🚀. 25% float short. Time to squeeezeeeeeeee
ABSI pump?? 24% float short. squeeze???
Bought CTM and ABSI for upcoming ERs
ABSI avg volume moving around 4.8 million. Earnings call coming in 12 days. Trading in a decent range to pick up!
Hoping for a quick turnaround 5 percent off ABSI today
Lots of bots \ scammers here I lost almost 10k USD this month following some of the suggestions made here Here are some real findings of mine after some research and do not take it for granted: APLD has made me 16% this night and I'm guessing it might go a little more up BLDE Q2 results will most likely be positive just like their Q1 and it will get you 10-20% up MVST Q2 results will be positive just like their Q1 and it will get you the same ABSI will go up pre results as it always had done PONY MDAI will go up this month Everyone in here is chasing the 10x biotech 🎢 and they end up losing more money than they can afford Small wins get you where you want to be at the end.
I just saw "this thing has no volum" Ffs I just lost almost 2 since yesterday but I made more with ABSI I'm gonna sell by EOD if nothing changes
What are thoughts on ABSI? Looks undervalued. Market didnt like announcement of common stock option to buy at $3
I'm down 3k today and spent ages trying to find the culprit, and it's just the dumb meme stocks. PNG, CLOV, CTM, BB, ABSI, KULR all down.
It has been breaking out recently and seemingly under the radar as of the last couple of days actually. As the rest of the market recovered for the last 3 months ABSI continued to stagnate and slip lower. It is just now starting to make a move. Don’t open your yap if you know nothing in regard to what you speak of.
More ABSI for me, and watching my XRP pile from almost a decade ago blossom
I sold Open calls this morning for ABSI calls. Not great, not terrible Something is amiss…in a good way? I don’t know why open is catching fire like this but maybe I buy more calls tomorrow
Why is ABSI mooning, fr
$ABSI seems to be going wild today, I think this can only be explained by something we haven't heard about publicly - can anyone shed any light?
ABSI coming up fast
ABSI is a sane investment not a penny
What do you feel about ABSI I’ve been quite heavily invested and it seems promising all things considered. Hoping for an exit around $14
RKLB can keep going up. Finally in the green there after all my losses in Feb. now if ABSI, LUNR and NBIS can just keep ticking, we’re golden!
**$ABSI is the biotech version of vaporware.** All hype, no substance. Let’s break it down: * **“AI + drug discovery”** is the same tired pitch 50 other biotechs are making. * **Zero animal testing?** Cool story — until the FDA still wants actual human data. * **AMD’s $20M investment?** That’s couch change for them. Doesn’t even register. * **Analyst targets?** Paid-for fiction. Stocks don’t trade on fairy tales. * **“Big partnerships”** with zero disclosed revenue or milestones? Smells like window dressing. * **ARK loading up?** Same ARK that’s been underwater on 80% of their biotech plays. ABS-101 might be their shot — but that’s years away. In the meantime, they’re just burning cash on compute power and press releases. Classic pump setup with nothing under the hood. **Verdict: Overhyped AI drug fairy tale. Watch your bag.**
I think ABSI is starting up
$ABSI (Absci) - the AI healthcare boom will be real and it’s backed by AMD.
ABSI is partnering with some of these big pharma companies you’re talking about.
I'm wondering if you got into ABSI?
Full port ABSI for earnings take off 🚀
Not answering your question, but be careful with ABSI earnings that are coming up soon.
Is ABSI going to recover? Im down 40%
Is ABSI and RXRX going to recover?
Whatever happened to that "all-in" on ABSI guy from a month ago? Gave a nice DD and all that. Just wondering how he is holding up.
Did you ever post your ABSI play?
I'm buying ABSI tomorrow cause it gonna go bigly green soon
My dumbass went heavy into NBIS and ABSI a few weeks ago and didn’t sell last week when I was up 25% and 40% respectively.
Speaking of biotech research, what does your tool say about $ABSI? I bought in quite a bit, but it dropped substantially immediately after. I'm pretty confident that it'll bounce back and beyond eventually considering the big push in the AI space, but seeing my investment down nearly 30% right now sure stings
I did. ABSI. RSI is LOOOOWWW. IDK. Maybe.